Rankings
Pricing
Log In
Free Trial
US-listed companies
Silk Road Medical Inc
Silk Road Medical Inc
SILK
Market cap
$1.1B
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Net loss
-52
-47
-50
-55
-56
Other Depreciation and Amortization
-
1
1
2
3
Stock-based compensation expense
3
7
15
25
39
Amortization of premiums (accretion of discounts) on investments, net
0
-0
-1
1
6
Amortization of Debt Issuance Costs and Discounts
0
0
0
0
0
Amortization of right-of-use asset
-
1
1
1
1
Paid-in-Kind Interest
1
0
-
1
1
Loss on extinguishment of debt
-
-1
-
-0
-
Loss on disposal of property and equipment
-
-0
-0
-0
-0
Accounts Receivable, Credit Loss Expense (Reversal)
0
-0
0
-0
0
Inventory Write-down
0
0
0
0
0
Accounts receivable
2
0
3
6
6
Inventories
5
2
6
1
11
Prepaid expenses and other current assets
1
-0
1
1
2
Other assets
-1
-0
0
0
0
Accounts payable
1
1
-1
1
3
Accrued liabilities
5
0
4
2
3
Other liabilities
-1
0
-1
-1
-1
Repayment of interest paid in kind
-
4
-
-
-
Net cash used in operating activities
-30
-42
-39
-33
-32
Purchases of property and equipment
1
1
5
5
2
Proceeds from sale of property and equipment
-
-
0
-
-
Purchases of investments
69
80
-
168
175
Proceeds from maturity of investments
-
71
77
11
169
Net cash provided by (used in) investing activities
-70
-9
73
-162
-7
Proceeds from Issuance Initial Public Offering
109
71
-
109
-
Proceeds from long-term debt, net
-
49
-
74
-
Proceeds from issuance of common stock
3
5
7
6
4
Principal repayment of long-term debt
-
40
-
49
-
Payments of prepayment penalty and lender fees
-
2
-
-
-
Proceeds from Noncontrolling Interests
-
-
0
-
-
Proceeds from Noncontrolling Interests
-
-
0
-
-
Net cash provided by financing activities
114
82
7
140
4
Net cash provided by financing activities
114
82
7
140
4
Net change in cash, cash equivalents and restricted cash
14
30
41
-55
-35
Cash paid for interest
4
8
2
4
6
Capital Expenditures Incurred but Not yet Paid
0
0
1
0
0
Unpaid deferred offering costs
-
0
-
-
-
Right-of-use asset obtained in exchange for lease obligation
4
-
3
1
3
Right-of-use asset obtained in exchange for lease obligation
4
-
3
1
3